Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival
Marin E. Nelson(The University of Sydney), Kyle L. Hoehn(UNSW Sydney), Frances L. Byrne(University of Virginia), Sujoy Lahiri(University of Virginia), Stephen H. Caldwell(University of Virginia), Nigel Turner(Garvan Institute of Medical Research), Jill K. Slack‐Davis(University of Virginia), Stefan R. Hargett(University of Virginia), Ellen M. Olzomer(UNSW Sydney), Carolin Lackner(Ludwig Boltzmann Institute Applied Diagnostics), David Breen(University of Virginia), Lindsay E. Wu(UNSW Sydney), Jenny D.Y. Chow(University of Virginia), Gregory J. Cooney(Garvan Institute of Medical Research), David E. James(The University of Sydney)
Cited by 96
Related Papers
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
|Hepatology|2003|2.1k
Liver biopsy†
|Hepatology|2008|1.9k
Regulated transport of the glucose transporter GLUT4
|Nature Reviews Molecular Cell Biology|2002|1.2k